Potential COVID-19 treatment has ‘clear and compelling’ effect, says biopharma with US HQ in Raleigh
RedHill Biopharma, an Israeli company with U.S. headquarters in Raleigh, says one of its drug candidates, opaganib, completely inhibited the replication of the coronavirus that causes COVID-19 in a laboratory study.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
